Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Insight Brief
September 06, 2017

Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges
Outbreaks of Zika virus have been reported in several areas including tropical Africa, Southeast Asia and the Pacific Islands. This infectious disease can lead to microcephaly and other severe fetal brain defects, which presents a significant public health challenge. Because of this, an effective Zika vaccine is urgently needed, but there are delays in development due to a number of complexities.

Discover the role of the central laboratory in Zika vaccine development and how you can proactively avoid challenges along the development continuum.

Authors:
Wayne Hogrefe, Ph.D., D (ABMLI), Vice President, Vaccine unit
Paul Rhyne, Ph.D., Scientific Director, Bioanalytical and ADME Immunoassay Services

Related Services:
Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Q2 Solutions Anti-infective and Vaccine Development Services

Assays to drive success in anti-infective and vaccine development

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Read More